Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.77 | 0.77 | 0.00 |
Shares | 98.02 | 98.02 | 0.00 |
Convertible | 0.05 | 0.05 | 0.00 |
Preferred | 0.27 | 0.27 | 0.00 |
Other | 0.89 | 0.89 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.18 | 20.61 |
Price to Book | 4.71 | 4.60 |
Price to Sales | 2.18 | 2.53 |
Price to Cash Flow | 18.04 | 17.54 |
Dividend Yield | 1.16 | 1.10 |
5 Years Earnings Growth | 10.34 | 10.23 |
Number of long holdings: 120
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly and Co | - | 7.06 | - | - | |
UnitedHealth Group Inc | - | 5.85 | - | - | |
Novo Nordisk B | DK0062498333 | 5.18 | 928.8 | -0.92% | |
Merck & Co Inc | - | 3.63 | - | - | |
AstraZeneca | GB0009895292 | 3.57 | 12,296.0 | -0.87% | |
AbbVie Inc | - | 3.36 | - | - | |
Sanofi | FR0000120578 | 2.49 | 89.52 | -0.71% | |
Boston Scientific Corp | - | 2.31 | - | - | |
Vertex Pharmaceuticals Inc | - | 2.30 | - | - | |
Abbott Laboratories | - | 2.27 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Research D | 15.17B | 10.08 | 7.33 | 13.53 | ||
Janus Balanced I | 10.64B | 3.21 | 3.28 | 8.16 | ||
Janus Henderson Balanced Portfolio | 8.06B | 3.16 | 3.08 | 7.88 | ||
Janus Enterprise I | 7.45B | 3.56 | 3.22 | 12.37 | ||
Janus Enterprise N | 6.11B | 3.59 | 3.32 | 12.47 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review